News - Herceptin, Rare diseases


Current filters:

HerceptinRare diseases

Popular Filters

Roche signs up to $490 million accord with PTC Thera for SMA program; and deal with Galena


Swiss drug major Roche (ROG: SIX) has signed a licensing agreement with privately-held US firm PTC Therapeutics…

Galena BioPharmaHerceptinLicensingNeuVaxOncologyPharmaceuticalPTC TherapeuticsRare diseasesResearchRoche

Back to top